266 related articles for article (PubMed ID: 10233933)
1. Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.
Kiernan RE; Ono A; Freed EO
J Virol; 1999 Jun; 73(6):4728-37. PubMed ID: 10233933
[TBL] [Abstract][Full Text] [Related]
2. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
Kiernan RE; Ono A; Englund G; Freed EO
J Virol; 1998 May; 72(5):4116-26. PubMed ID: 9557701
[TBL] [Abstract][Full Text] [Related]
3. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
Ono A; Freed EO
J Virol; 1999 May; 73(5):4136-44. PubMed ID: 10196310
[TBL] [Abstract][Full Text] [Related]
4. Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutant.
Huang M; Zensen R; Cho M; Martin MA
J Virol; 1998 Mar; 72(3):2047-54. PubMed ID: 9499059
[TBL] [Abstract][Full Text] [Related]
5. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein.
Manrique JM; Celma CC; Hunter E; Affranchino JL; González SA
J Virol; 2003 Oct; 77(20):10881-8. PubMed ID: 14512538
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the primer grip of human immunodeficiency virus type 1 reverse transcriptase impair proviral DNA synthesis and virion maturation.
Yu Q; Ottmann M; Pechoux C; Le Grice S; Darlix JL
J Virol; 1998 Sep; 72(9):7676-80. PubMed ID: 9696874
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles.
Liao WH; Huang KJ; Chang YF; Wang SM; Tseng YT; Chiang CC; Wang JJ; Wang CT
J Virol; 2007 May; 81(10):5155-65. PubMed ID: 17344306
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
10. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants.
Wang CT; Barklis E
J Virol; 1993 Jul; 67(7):4264-73. PubMed ID: 7685414
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.
Lee YM; Tang XB; Cimakasky LM; Hildreth JE; Yu XF
J Virol; 1997 Feb; 71(2):1443-52. PubMed ID: 8995670
[TBL] [Abstract][Full Text] [Related]
12. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.
Wang CT; Zhang Y; McDermott J; Barklis E
J Virol; 1993 Dec; 67(12):7067-76. PubMed ID: 7693966
[TBL] [Abstract][Full Text] [Related]
13. Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.
Dettenhofer M; Yu XF
J Virol; 1999 Jun; 73(6):4696-704. PubMed ID: 10233929
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.
Paillart JC; Göttlinger HG
J Virol; 1999 Apr; 73(4):2604-12. PubMed ID: 10074105
[TBL] [Abstract][Full Text] [Related]
15. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
Joshi A; Nagashima K; Freed EO
J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
[TBL] [Abstract][Full Text] [Related]
16. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
Ono A; Orenstein JM; Freed EO
J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
[TBL] [Abstract][Full Text] [Related]
17. Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1.
Bleiber G; Munoz M; Ciuffi A; Meylan P; Telenti A
J Virol; 2001 Apr; 75(7):3291-300. PubMed ID: 11238855
[TBL] [Abstract][Full Text] [Related]
18. The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA.
Liang C; Rong L; Morin N; Cherry E; Huang Y; Kleiman L; Wainberg MA
J Virol; 1997 Dec; 71(12):9075-86. PubMed ID: 9371564
[TBL] [Abstract][Full Text] [Related]
19. Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.
Anderson-Daniels J; Singh PK; Sowd GA; Li W; Engelman AN; Aiken C
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413124
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein.
González SA; Affranchino JL
Virology; 1995 Jul; 210(2):501-7. PubMed ID: 7618287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
